Shareholding disclosure

Addex Therapeutics Ltd

Collectively declared rate

4.95%

Threshold

Crossed upwards

Timeline

Published

10.12.2009

Transaction

02.12.2009

Voting rights breakdown

Voting rights acquired4.95%

Voting rights sold0%

Below threshold0%

Declared beneficial owners · 6

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TB9C800014

Beneficial owner

S.R. One, Limited

Declared address

S.R. One, Limited, Philadelphia, PA 19102

Sale in the market S.R. One, Limited is a wholly-owned subsidiary of GlaxoSmithKline plc

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Addex Therapeutics Ltd

Addex Therapeutics Ltd10.12.2009TB9C800014

Disclosure summary

S.R. One, Limited disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 10.12.2009, at 4.95% of voting rights. The filing groups 6 beneficial owners declared together. Notice category: Group of shareholders.

Disclosed position

Collectively declared rate

6 people

4.95%

Voting rights acquired

Voting rights acquired4.95%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Declared beneficial owners · 6 people

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Disclosure detail

S.R. One, Limited disclosed a holding in Addex Therapeutics Ltd, published on 10.12.2009.

Publication date10.12.2009

Transaction date02.12.2009

Issuing companyAddex Therapeutics Ltd

Beneficial ownerS.R. One, Limited

Declared addressS.R. One, Limited, Philadelphia, PA 19102

CategoryGroup of shareholders

Voting rights acquired4.95%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTB9C800014

Conditions

Sale in the market S.R. One, Limited is a wholly-owned subsidiary of GlaxoSmithKline plc

Source: SIX Exchange Regulation · Publication date: 10.12.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open